Loading

Annals of Pediatrics and Child Health

Post-Operative Analgesic Effect of Caudal Neostigmine added to Bupivacaine as Compared with Caudal Bupivacaine alone for Pediatric Elective Infra Umbilical Surgery. A Prospective Cohort Study

Research Article | Open Access | Volume 11 | Issue 3

  • 1. Department of Anesthesia, Debre Markos University, Ethiopia
  • 2. Department of Anaesthesia, Addis Ababa university University, Ethiopia
  • 3. Department of Anaesthesia, Hawassa University University, Ethiopia
+ Show More - Show Less
Corresponding Authors
Yitayal Guadie, Department of Anesthesia, School of Medicine, Debre Markos University, Ethiopia
Abstract

Background: Caudal epidural block is one of the most commonly used, popular, safe and easy regional anesthetic techniques to be performed in children undergoing infra-umbilical surgeries. The main disadvantage of single-shot caudal anesthesia is the short duration of action. Neostigmine is one of adjuvant with local anesthetic agents to improve the efficiency and quality to prolong the duration of analgesia after surgery. This study aimed to assess the effect of adding neostigmine to bupivacaine on post-operative analgesia in pediatric patient during infra umbilical surgery

Methods: Hospital based Prospective cohort study was conducted among 68 children’s, whose aged is between 1-12 years, American Association of Anesthesiologists I & II undergoing elective infra umbilical surgery received caudal bupivacaine alone or bupivacaine with neostigmine. A systemic random sampling technique was used to select study participants. Postoperative severity of pain, time to request and total analgesic consumption was evaluated up to 24 hours after the operation. Based on the normality assumption, the analysis was done by independent sample t- test, a chi-square test and Mann– Whitney U-test. A p-value <0.05 was considered as statistically significant.

Results: In this study the median duration of postoperative analgesia in neostigmine group was 644 min while it was 322.5 min in bupivacaine alone group with statistically significant difference. With a p-value <0.0001. Median postoperative pain severity was being statistically significant difference at 4th, 8th, 12th and 24th hour with p-value of <0.05 but it was statistically insignificant at arrival, 1st and 2nd hour. Median post-operative analgesic consumption in mg within 24 h neostigmine group was 250 and bupivacaine alone group was 750 statistically significant with p-value of <0.0001.

Conclusion: Caudal neostigmine with bupivacaine provides effective post-operative analgesia in pediatrics undergoing infra-umbilical surgeries.

Keywords

Caudal block, Bupivacaine, Neostigmine, Analgesic effect, Infra umbilical surgery

ABBREVIATIONS

ASA: American Society of Anesthesiologist; BAG:Bupivacaine Alone Group; BNG: Bupivacaine Neostigmine Group; CB: Caudal Block; FLACC: Face Legs Activity Cray Consolable; NRS: Numerical Rating Scale; OPS: Objective Pain Scale; PONV: Postoperative Nausea and Vomiting; POP: Postoperative Pain; SPSS: Statistical Package for Social Science; TASH: Tikur Anbesa Specialized Hospital

INTRODUCTION

Based on an international association study pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage [1].

The caudal block was first described in 1933 by Campbell and today it has become one of the most popular regional analgesic techniques [2].

Caudal block is useful for infra-umbilical surgery interventions in children for providing pain relief intra and post-operatively and also to reduce intraoperative inhalational or opioid agent consumption [3,4]. The main disadvantage of caudal administration of bupivacaine alone has a short duration of action (120 -150 min). There is a concern regarding the use of caudal catheters to administer repeated doses or infusions of local anesthetic due to the risk of infection [5,6]. Caudal opioids have some adverse effects like nausea, vomiting, pruritus, urinary retention, and respiratory depression [7].

According to a WHO report, 80% of people worldwide do not receive adequate treatment for pain based on that only one in four patients had adequate relief from POP [8-13]. In Ethiopia, intra and postoperative analgesia is commonly achieved by the use of suppository paracetamol (PCM).

Neostigmine acts by inhibiting the breakdown of acetylcholine in endogenous neurotransmitters by producing analgesia when given in a central neuraxial route [10].

Therefore, this study was conducted to evaluate the effect of adding neostigmine to bupivacaine for the prevention of postoperative pain in pediatric patients undergoing infraumbilical surgeries.

METHODS AND MATERIALS

Study design and sampling technique prospective cohort study design was conducted from October 30, 2019, G.C to January 30, 2020, at Tikur Anbesa specialized hospital which is located in Addis Ababa, Ethiopia. A total of sixty-eight pediatric patients were analyzed whether they received caudal block with the additive of neostigmine or bupivacaine alone group after induction of anesthesia over these three months.

The study was registered at http://www.researchregistry. com with the UIN: research registry 7478. This work is reported in line with STROCSS criteria from http://www.strocssguideline. com.

Data collection tool and procedure

After ethical approval was obtained from Addis Ababa University ethical committee and informed consent was taken from parents 68 patients belonging to ASA physical status I and II in the age range of 1- 12 years of either sex, for infra-umbilical surgeries were recruited.

The sample size was divided into two groups BAG and BNG, having 34 patients in each group receiving caudal bupivacaine 0.25% 1ml/kg and BNG received caudal bupivacaine 0.25% 1ml/kg plus neostigmine 2µg/kg. Failed caudal block, day case surgery, additive drugs used during caudal analgesia other than neostigmine, and dose other than 1ml/kg bupivacaine and 2 µg / kg neostigmine were excluded from the study.

Induction of anesthesia was selected by an anesthesiology resident student, MSc anesthesia student, and MSc anesthetists done with Propofol, thiopental, ketamine, and maintenance with halothane or Isoflurane. The caudal block was done left lateral decubitus position. Patient monitoring attached ECG, noninvasive blood pressure, pulse oximeter, precordial stethoscope, and time to start induction was documented. The postoperative time patients were transferred to PACU and to the ward when they recover from anesthesia. The patient was observed by trained nurses and pain was managed based on patient complaints. Either FLACC/ NRS pain score was assessed & measured at arrival, 1st, 2nd, 4th, 8th, 12thand 24thhour after the end of the surgery, time to first analgesic request, and total analgesic consumption in 24 hrs. In addition, adverse effects such as postoperative nausea and vomiting, motor block, urinary retention, and sedation were documented when it is reported within 24 hours

Variability of the study

The dependent variable this study was Pediatrics who received caudal neostigmine or bupivacaine, ASA status I and II, and Pediatric patients aged from 1-12years. The independent variable of this study was Failed caudal block, Additive drugs used during caudal analgesia other than neostigmine, and Dose other than 1ml/kg bupivacaine and 2 µg /kg neostigmine.

Data Analysis Procedure

Statistical analysis was performed using the statistical package for the social sciences, version 26 (SPSS). Descriptive statistics were used to summarize data, tables, and figures to display the result. Shapiro Wilk test was used to test normality while homogeneity of variance was assessed by using Levene’s test for equality of variance, chi-square test was used to analyze categorical variables. Mann-Whitney U-test was used to analyze ordinal and non-normally distributed variables, with a power of 95% confidence level. In this study, a p-value <0.05 was considered statistically significant.

RESULTS

A total of sixty eight pediatric patients (34 patients in each group) were analyzed whether they received caudal block with additive of neostigmine or bupivacaine alone group after induction of anesthesia.

Socio demographic and preoperative patient characteristic The Socio demographic patient characteristics were comparable for all patients in the two groups. But there is no statistically significant difference between the two groups p- value >0.05 (Table 1).

Table 1: Socio demographic and preoperative patient characteristic between BN & BA groups in pediatric elective infra-umbilical surgery.

Variables  Bupivacaine alone group  (n=34)    Bupivacaine with neostigmine group  (n=34) P-value
 Sex   
Male n(%) 21(61.8 %) 27(79.4 %) 0.11
Female n (%) 13(38.2 %) 7(20.6 %)
Age(years)* 4 (2-5.25) 3(2-6) 0.941
Weight(kg)* 14(10-19.25) 4.5(10-20) 0.711
ASA Status   
ASAI n (%) 26(76.5 %) 27(79.4 %) 0.77
ASAII n (%) 8(23.5 %) 7 (20.6 %)
Type of surgery
Urogenital n (%) 12 (35.5 %) 19 (55.9 %)  
   GI/Lower abdominal n (%) 22 (64.7 %) 13 (38.2 %)  
Calf venous malformation n (%) 0 (0%) 2 (5.9 %)  
Duration of surgery (min)* 135 (90-176.25 ) 120(87.5-162.5 )       0.449
Duration of anesthesia (min)* 152.5 (103.75-188.75 ) 130 (100-176.25 )        0.332
Induction agent
Thiopental 13(38.2%) 14(42.2%) 0.722
Propofol 8(23. 5%) 10(29.4)
Ketamine 13(38.2%) 10(29.4%)

Hemodynamic response before and after caudal anesthesia between two groups

There was no statistically significant difference in baseline vital sign, before, after skin incision, immediately at arrival and 60 minutes in hemodynamic response (PR and MAP) between two groups with P-value >0.05 (Table 2).

Table 2: Hemodynamic response before and after caudal analgesia between BN & BA groups in pediatrics elective infra-umbilical.

Variables  Bupivacaine alone group Bupivacaine with neostigmine group(n=34) P- value
(n=34)
Base line pulse rate** 124.91±15.927 121.91±22.28 0.525
Base line MAP *  69 (63-82) 72.5 (64.75-80) 0.956
Vital sign before skin incision
      Pulse rate**  126.18±17.02 122.82±21.67 0.481
     Mean arterial pressure*  71(63-82) 70 (64-79) 0.703
Vital sign after skin incision
      Pulse rate*  124 (109.75-133.5) 124(115.5-130) 0.636
      Mean arterial pressure*   67.5 (60-80) 64 (60-72) 0.141
Vital sign  immediately at arrival (PACU)
Pulse rate**  115.97±9.22  112.88±10.06 0.192
Mean arterial pressure  * 66(60.75 -72)  65.5(60-67.5)                            0.619
Vital sign within 60 min 
 Pulse rate ** 114.65±8.339 115.65±9.764 0.532
Mean arterial pressure * 73(66.5-80.5) 70(66-78.5)    0.507

NB: BN=bupivacaine with neostigmine added, BA= bupivacaine alone,**= mean ±SD, *=  =median(Inter-quartile range), PR= Pulse rate in beat per minute, MAP = mean arterial blood pressure in mmhg, Independent sample t-test for normal distributed data and Mann -Whitney U test for non-parametric test  was used, p-value < 0.05 is significant.

Comparison of postoperative pain severity by FLACC/ NRS pain rating scale between two groups.

The median FLACC/NRS score were comparable immediately at PACU, 1st and 2nd hour post operatively between bupivacaine alone and neostigmine with bupivacaine groups with statistically insignificant difference (p- value of >0.05).But the median FLACC/NRS were lower in neostigmine with bupivacaine group at 4th, 8th, 12th and 24th hour post operatively with statistically significant (p-value of <0.05) (Table 3 & Figure 1).

Table 3: Comparison of postoperative pain severity by FLACC/NRS pain rating scale between BN & BA groups in pediatrics elective infra-umbilical surgery.

           Variable * Bupivacaine alone group (n=34) Bupivacaine with neostigmine  group(n=34) P-value
pain FLACC/NRS Score
Immediately postoperatively    1(0-1) 1(0-1.25) 0.747
1st h post Postoperatively    1(0-1) 0(0-1) 0.209
2nd h post-operatively   1(0-2) 0(0-1) 0.159
4th h post-operatively  3(2-3) 2(1-2.25) 0.001*
8th h post-operatively  3(2-4.25) 2(1-3) <0.0001*
12th h post –operatively  4(4-5) 3(2-3) <0.0001*
24th h post-operatively   5(3.75-5) 3(2-3) <0.0001*

NB: BN=bupivacaine with neostigmine, BA= bupivacaine alone, * = M =median; (Inter-quartile range),*= statistically significant, Mann -Whitney U test was used, p-value < 0.05 is significant.

Comparison of postoperative pain severity using 11 points FLACC/NRS (0-10) score between BN & BA groups in pediatrics elective infraumbilical surgery

Figure 1: Comparison of postoperative pain severity using 11 points FLACC/NRS (0-10) score between BN & BA groups in pediatrics elective infraumbilical surgery.

Comparison of time to first analgesia request, total dose of analgesic consumption in mg 24 h, Proportion of pt. need analgesia in 24h n (%) & number of analgesic request in 24h between two groups.

The result for time to first analgesia request found that neostigmine with bupivacaine group prolongs the analgesia duration than in bupivacaine alone group with statistically significant (p- value <0.05 (Table 4 & Figure 2).

Table 4: Comparison of time to first analgesia request, total dose of analgesicConsumption in mg 24 h & number of analgesic request in 24h between BN &BA groups in pediatrics elective infra-umbilical surgery

Variables * Bupivacaine alone group (n=34)                 Bupivacaine within neostigmine  (n=34) p-value
Time to first analgesic request minutes     322.5(242.5-375) 644(450-1440)                <0.0001*
 
 
Total dose of analgesia 750(500-750)            250(0-500)             <0.0001*
Paracetamol
consumption in mg 24 h
Number of  analgesic request  in 24h  3(3-4) 1.5(0-2) <0.0001*
Proportion of pt. need analgesia in 24h n (%) 34(100%) 23(67.6%) <0.0001*

NB: *= statistically significant, * =median or inter-quartile range, chi-square (x2) test and Mann -Whitney U test was used, p-value < 0.05 is significant.

Comparison of time to first analgesia request between BN and BA groups within 24 hours in minutes groups in pediatrics elective infraumbilical surgery.

Figure 2: Comparison of time to first analgesia request between BN and BA groups within 24 hours in minutes groups in pediatrics elective infraumbilical surgery.

Total dose of analgesic consumption paracetamol in mg within the first 24 h in neostigmine with bupivacaine group median were less used than bupivacaine alone group which is statistically significant (p-value <0.05).

The number of analgesic request in 24 h median compared in neostigmine with bupivacaine group were less number request than bupivacaine alone group with statistically significant (p-value <0.05).

Incidence of post-operative complication between two groups

The incidence of post-operative nausea and vomiting over 24 hours is 2.9% in both groups. But statistically insignificant difference between two groups with and also the other complication like motor/leg weakness, sedation and urinary retention statistically insignificant difference between the two groups with (p-value >0.05) (Table 5 & Figure 3).

Table 5: Incidence of post-operative nausea & vomiting over 24 hour complication between two groups BN & BA groups in pediatrics elective infra-umbilical surgery.

Post-operative complication Bupivacaine alone group(n=34) Bupivacaine with neostigmine P-value
Within 24 h (n= %) group (n=34)
Nausea and vomiting (n %) 1(1.45%) 1 (1.45%) 1
Motor/leg weakness (n %) 0 0  
Sedation (n %) 0 0  
 Urinary retention (n %) 0 0  

NB: (n= %) = number (proportion), Bupivacaine alone group (BA), Bupivacaine with neostigmine group (BN), chi-square (x2)–test was used with p-value <0.05 is significant.

Incidence of post-operative nausea & vomiting over 24 hour complication between two groups BN & BA groups in pediatrics elective  infra-umbilical surgery.

Figure 3: Incidence of post-operative nausea & vomiting over 24 hour complication between two groups BN & BA groups in pediatrics elective infra-umbilical surgery.

DISCUSSION

In our study, the Socio-demographic characteristic of age, Wight, gender, ASA status, duration of surgery, and duration of anesthesia were comparable in both groups, and hemodynamic parameters vital signs like baseline, before and after skin incision by mean or median (blood pressure & heart rate). There were no statistically significant differences between the two groups (p-value>0.05) which is similar to the study conducted in Turkey by Dilek Memis and in India by Dr. Tahira Akhter et al [14,15]

In this study, the result with a median duration of postoperative analgesia was 322.5 minutes vs 644 minutes in the bupivacaine alone group and neostigmine with bupivacaine group postoperative. Respectively (P-value<0.05). This finding is similar to the study done in Pakistan by Mohsin Riaz et al., showed that the mean duration of postoperative pain relief in BNG was 11.97 ± 3.80 h and BAG was 6.70 ± 2.12 h statistically significant difference with a p-value <0. 001 [16].

Our study also shows a comparable result with a study done by S Fyneface -Ogan etal in Nigeria 2014 on the comparison of caudal bupivacaine and neostigmine to relieve postoperative pain in children showing that the mean postoperative duration of analgesia was 4.77 ± 0.8 vs 7.7 ± 1 h in bupivacaine alone group and neostigmine with bupivacaine group respectively [17].

In contrast to this study, research done in Turkey by Dilek Memis et al., showed that the mean duration of postoperative pain relief did not differ bupivacaine alone group was 15.40 ± 10.97 h and neostigmine with bupivacaine group was 15.45 ± 10.99 with (P-value > 0.05) [18].

In this study, the median postoperative pain severity was assessed by FLACC/NRS scale between two groups at the 4th, 8th, 12th, and 24th hours after surgery with a p-value of <0.05. But it is statistically insignificant at arrival (PACU), 1st and 2nd h. is finding were similar to the result done by Dr. Emil Batarseh 2015 in Arab West Asia which showed that postoperative pain severity is statistically significant at 4 th,8th,12th, and 24th hour with the p-value of <0.05 while it was insignificant at arrival, 1st and 2nd hour [19].

Another study conducted in India by Bhardwaj N et al showed that there was no mean duration of postoperative pain severity between the two groups which is incomparable with our study finding [20].

In this study, the median postoperative analgesia consumption in mg within 24 h in neostigmine group was 250 and bupivacaine alone group was 750 statistically significant with a p-value of <0.0001.

In another study conducted in Arab West Asia by Dr. Emil Batarseh [21], and in Egypt by El-Miseery et al. [22], postoperative total analgesia consumption is lower in the neostigmine with bupivacaine group than bupivacaine alone group in 24 hours with p-value <0.05.

According to the result of this study, postoperative nausea and vomiting were too low in bupivacaine alone and neostigmine with bupivacaine groups respectively, which is statistically insignificant between the two groups (p-value>0.05).

In contrast with our study, research conducted by Batra YK et al. [12], and Kaushal D [13] in India found that postoperative nausea and vomiting were statistically significant. The possible reason may be due to they had used a higher dose of neostigmine.

CONCLUSION

Caudal analgesia using neostigmine added with bupivacaine (2µg/kg) is increased the duration of postoperative analgesia for pediatric elective infra umbilical surgical procedures without any significant side effects.

Recommendation

We recommended the use of additive neostigmine with bupivacaine for caudal analgesia undergoing infra-umbilical pediatrics surgeries to prolong postoperative analgesic effectiveness.

We also recommended additional randomized controlled study

ACKNOWLEDGMENT

We would like thank to Collage Health Science, Addis Ababa University for the financial support for corresponding authors to give constructive suggestions and comments, supervisors’, data collectors, and study participants.

We would like also than Addis Ababa University library to cite the preprint version of this study.

Data Availability

All data analyzed during this study are included within the article.

Ethical Approval: Ethical clearance was obtained from the department ethical clearance committee college of health science department of anesthesia Addis Ababa University before the start of the study. Get permission from TASH clinical director’s office after submission of an official letter

CONSENT

The importance of the study was explained and written informed consent was obtained from each participant relative by the data collector. Participant’s involvement in the study was on voluntary bases, participants who were not willing to participate in the study & those who wish to quit their participation at any stage were informed to do so without any restriction.

Disclosure The publisher to recommend that the preprint version of the previous study was cited (1).

This work is reported at line with STROCSS criteria at www. strossguideline.ccom.

AUTHORS’ CONTRIBUTIONS

All authors should have made substantial contributions to all of the following: the conception and design of the study, or acquisition of data, or analysis and interpretation of data, drafting the article or revising it critically for important intellectual content, final approval of the version to be submitted.

REFERENCES

1. Rolf T. International association for study of pain, Subcommittee on Taxonomy. Pain terms: a list with definitions and notes on usage. 1979; 6: 249-252.

2. Serbülent Gökhan Beyaz, Tokgoz O, Tufek A. Caudal epidural block in children and infants. Ann Saudi Med 2011; 31: 494-497.

3. Selvakumaran P, Sankita K, Vasanti K. Comparative study of caudal Ropivacaine with ropivacaine &

4. Ketamine for postoperative analgesia in pediatric patients. Indian J Clin Anesth. 2017; 4: 489-493.

5. Lonnqvist PA. Adjuncts to caudal block in children-Quo Vadis? British J Anesth. 2005; 95: 431-433.

6. de Beer DAH, Thomas MH. Caudal additives in children Ðsolutions or problems? British J Anesth. 2003; 90: 487-498.

7. Vandana Pandey, Mohindra BK, Sodhi GS. Comparative evaluation of different doses of intrathecal neostigmine as an adjuvant to bupivacaine for postoperative analgesia Anesthesia: Essays and Researches. 2016; 10.

8. Stephen R. Connor, Maria Cecilia Sepulveda Bermedo. Global Atlas of palliative care at the end of life. World health organization. 2014.

9. Mohsin Riaz Askri. Postoperative analgesia in children. Professional Med J. 2018; 25: 1069-1072.

10. Dilek Memis, Turan A, Kaya G, Sut N, Pmakcu Z, Beyhan K. Caudal neostigmine for postoperative analgesia in pediatric surgery. Blackwell Publishing Ltd, Pediatr Anesth. 2003; 13: 324-328.

11. Emil Batarseh, Mjali Z, Nsour N, Daaja M, Nabukhotna O. Caudal bupivacaine neostigmine effect on postoperative pain relief in children. J Royal Med Services. 2015; 22: 24-29.

12. Batra YK, Arya VK, Mahajan R, Chari P. Dose response study of caudal neostigmine for postoperative analgesia in pediatric patients undergoing genitourinary surgery. Blackwell Publishing Ltd. Pediatr Anesth. 2003; 13: 515-521.

13. Kaushal D, Singh V, Abbas H, Mallik A, Singh G. Caudal bupivacaine neostigmine for perioperative analgesia in pediatric patients undergoing infraumbilical surgeries. Int J Anesthesiol. 2008; 21: 1-7.

14. Tahira Akhter. Effectiveness of co-administration of neostigmine and ropivacaine in children for caudal block. 2019.

15. Research. JoCaD. Neostigmine as an Adjuvant to Caudal Bupivacaine in Pediatric Population. J Clin Diagnostic Res. 2018; 12.

16. Bhardwaj N, Yaddanapudi S, Ghai B, Wig J. Neostigmine does not prolong the duration of analgesia produced by caudal bupivacaine in children undergoing urethroplasty. J Postgrad Med. 2007; 53.

17. Fyneface-Ogan S, Tobin M, Mato CN. A comparative study between caudal bupivacaine and bupivacaine co-administered with neostigmine for postoperative analgesia in children. 2014; 21: 51-56.

18. Muhozya AP. Caudal block for pain relief in children undergoing perineal and lower abdominal surgeries. 2013.

19. Abdulatif M. Caudal neostigmine, bupivacaine and their combination for postoperative pain management after hypospadias surgery in children. International anesthesia research society. 2002; 95: 1215- 1218.

20. El-Miseery. Prospective randomized study comparing the efficacy of caudal bupivacaine versus bupivacaine–neostigmine in children undergoing congenital inguinal hernia repaired. Tanta Medical J. 2018; 46 239-244.

21. Ataro G. Effectiveness of Caudal Epidural Block using Bupivacaine with Neostigmine for Pediatric lower extremity orthopedic surgery in cure Ethiopia children’s hospital. J Anesth Clin Res. 2014; 5.

22. Yitayal G, Wosenyeleh A, Senait A, Amanu G. Assessment of postoperative analgesic effect of caudal neostigmine added to bupivacaine for pediatric elective infra umbilical surgery. 2020.

23. Yitayal G WA, Senait A. Post-Operative Analgesic Effect of Caudal Neostigmine added to Bupivacaine as compared with Caudal Bupivacaine alone for Pediatric Elective Infra Umbilical Surgery. 2020.

Guadie Y, Admasu W, Aweke S, Gashaw A, Debas S, et al. (2023) Post-Operative Analgesic Effect of Caudal Neostigmine added to Bupivacaine as Compared with Caudal Bupivacaine alone for Pediatric Elective Infra Umbilical Surgery. A Prospective Cohort Study. Ann Pediatr Child Health 2023; 11(3): 1309.

Received : 20 Jun 2023
Accepted : 20 Jul 2023
Published : 29 Jul 2023
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X